中國資源交通(00269.HK)收到復牌指引 續停牌
中國資源交通(00269.HK)公布,再自聯交所收到一封函件,當中載列公司恢復股份於聯交所買賣的指引。根據復牌指引,公司應刊發上市規則規定的所有未刊發財務業績,並說明任何審核修訂;證明公司遵守上市規則第13.24條;及公布所有重大資料,以便股東及投資者評估公司狀況。
聯交所要求,公司於其股份獲准恢復買賣之前,必須達成復牌指引、糾正導致其暫停交易的問題及全面遵守上市規則以令聯交所信納。聯交所進一步表示,倘情況發生變化,其可能修改或補充復牌指引。
應公司要求,股份已自今年7月3日起暫停於聯交所買賣,並將於進一步通知前繼續暫停。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.